Equities Analysts Offer Predictions for Trupanion, Inc.’s Q2 2025 Earnings (NASDAQ:TRUP)

Trupanion, Inc. (NASDAQ:TRUPFree Report) – Northland Capmk issued their Q2 2025 earnings per share estimates for Trupanion in a note issued to investors on Thursday, September 19th. Northland Capmk analyst G. Gibas anticipates that the financial services provider will post earnings per share of $0.00 for the quarter. The consensus estimate for Trupanion’s current full-year earnings is ($0.37) per share. Northland Capmk also issued estimates for Trupanion’s Q3 2025 earnings at $0.02 EPS, Q4 2025 earnings at $0.03 EPS and FY2025 earnings at $0.04 EPS.

TRUP has been the subject of several other reports. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. William Blair started coverage on Trupanion in a research report on Friday, July 19th. They issued an “outperform” rating for the company. Piper Sandler upped their price objective on Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a research report on Friday, August 9th. Stifel Nicolaus reaffirmed a “hold” rating and set a $30.00 price target (up from $22.00) on shares of Trupanion in a report on Friday, August 9th. Finally, Bank of America upped their target price on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Trupanion has an average rating of “Moderate Buy” and a consensus target price of $39.00.

Get Our Latest Stock Report on TRUP

Trupanion Stock Performance

Trupanion stock opened at $42.80 on Monday. Trupanion has a 1-year low of $19.14 and a 1-year high of $49.14. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average of $40.56 and a 200-day moving average of $31.75. The firm has a market cap of $1.80 billion, a P/E ratio of -66.88 and a beta of 1.74.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its quarterly earnings data on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The firm had revenue of $314.80 million during the quarter, compared to the consensus estimate of $309.33 million. During the same quarter in the previous year, the company posted ($0.33) earnings per share. The business’s revenue was up 16.3% on a year-over-year basis.

Insider Activity

In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock valued at $405,238 in the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Several large investors have recently made changes to their positions in the company. Sivia Capital Partners LLC purchased a new stake in Trupanion during the fourth quarter valued at approximately $31,398,000. 8 Knots Management LLC bought a new stake in Trupanion in the fourth quarter worth about $21,165,000. Wellington Management Group LLP grew its stake in shares of Trupanion by 34.6% during the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after buying an additional 630,155 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Trupanion in the second quarter worth approximately $4,739,000. Finally, Hosking Partners LLP bought a new stake in shares of Trupanion during the 2nd quarter worth approximately $3,523,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.